Cargando...
Pramlintide Reduces the Risks Associated with Glucose Variability in Type 1 Diabetes
BACKGROUND: This study was designed to determine whether pramlintide added to insulin therapy reduced the risks associated with extreme blood glucose (BG) fluctuations in patients with type 1 diabetes. METHODS: Self-monitored BG (SMBG) records were retrospectively analyzed from a randomized, double-...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Mary Ann Liebert, Inc.
2008
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2979337/ https://ncbi.nlm.nih.gov/pubmed/18715216 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/dia.2007.0295 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|